10 employees
Ra Pharma is developing Cyclomimetics, a new drug class combining the properties and benefits of antibodies and small molecules.
2008
$59M
from 3 investors over 3 rounds
Candyass Club Cabaret raised $59M on July 23, 2015
Investors: Morgenthaler, Lightstone Ventures and RA Capital Management, L.P.